Global Urinary Retention Therapeutics Market to touch US$ 7.5 billion in 2033, Stress Incontinence to comprise over 38% of all Treatments: FMI Study

The global urinary retention therapeutics market size is anticipated to attain an impressive valuation of USD 3.44 billion in 2023 and is projected to reach US$ 7.5 billion by 2033, expected to register a CAGR of 8.11% until 2033, as per a recently published Future Market Insights study. The market is anticipated to be fuelled …

Unstable Angina Therapeutics Market to expand at a CAGR of 5%, reaching a market value of US$ 6.6 billion by 2033 | FMI

According to a recently published Future Market Insights report, the global unstable angina therapeutics market is forecast to expand at a CAGR of 5% until 2033, reaching US$ 6.6 billion. Based on a Cleveland Clinic study, approximately 200,000 Americans suffer from unstable angina every year. Unstable angina is more prevalent among older people, men, and those …

Fuchs Endothelial Corneal Dystrophy (FECD) Market is expected to reach a valuation of US$ 370 Billion by 2033 | Says FMI Analyst

According to a recent FMI study, the global Fuchs Endothelial Corneal Dystrophy (FECD) market will grow at a 7.5% CAGR from 2023 to 2033. The market is expected to be valued at US$ 370 billion by the end of the assessment period. The primary variables impacting the market growth rate include an increase in the …

Difficile Infections (Clostridium Difficile Associated Disease) Market is expected to be worth US$ 1,448.75 million by 2033 | FMI Study

The worldwide Difficile Infections (Clostridium Difficile Associated Disease) Market is predicted to reach a valuation of US$ 809 Million in 2023, with a CAGR of 6% predicted from 2023 to 2033. Clostridium difficile infection (CDI) is a disease caused by toxic compounds produced by the spore-forming bacteria “Clostridium difficile” found in the intestinal tract. It …

HER2 Positive Gastric Cancer Market is expected to be valued at US$ 1779.8 million by 2033 | FMI

The global HER2 Positive Gastric Cancer Market is currently valued at US$ 1261.8 million in 2023, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 1779.8 million by 2033. “Increased disease burden and pipeline candidate approval are likely to drive the growth of the HER2 …

Chronic Wound Care Market is expected to reach valuation of US$ 31.46 Billion by 2033 | FMI Study

According to Future Market Insights, Chronic Wound Care is expected to grow at a CAGR of 7% between 2023 and 2033, reaching US$ 31.46 Billion in 2033. Sales grew at a CAGR of 6.5% from 2018 to 2023. New innovative products are expected to be introduced to the market as a result of growing research …

Electrosurgery Generators Market is expected to reach US$ 3.58 Billion by 2032

The Global Electrosurgery Generators Market is expected to be valued at US$ 1.71 Billion in 2022. The market is expected to grow at a 6.94% CAGR to reach US$ 3.58 Billion by 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on …

Bariatric Patient Room Market is expected to grow at a significant CAGR of 8% through 2032

The Bariatric Patient Room Market is predicted to be valued at $2,453.72 million in 2022, rising to $5,297.39 million by 2032. During the forecast period, demand for bariatric patient rooms is expected to expand at a strong CAGR of 8%. The number of bariatric admissions to healthcare facilities in the United States is increasing significantly. …

Bioprocessing Analytics Equipment Market projected to grow US$ 633.6 Million by 2028

Bioprocessing Analytics Equipment Market In 2022, market revenue is expected to reach US$ 485.1 million. The global market is estimated to reach $633.6 billion by 2028, growing at a 4.5% CAGR. Demand for bioprocessing analytics equipment makes up 2.7% of the worldwide biopharmaceutical equipment market. Over the projection period, high demand for pharmaceutical manufacturing is …

Whole Genome Amplification Market is predicted to record a CAGR of 7.0% through 2033

As the need for whole genome amplification (WGA) in forensics and genetic disorders grows, the whole genome amplification market is predicted to exceed US$ 5.5 billion by the end of 2033, according to Future Market Insights (FMI) in its market analysis. Sales of whole genome amplification are expected to reach $2.8 billion by 2023. Between …